The Latest Breaking News from AbbVie Inc

The pharmaceutical industry’s inelastic demand for its products helps it to weather economic downturns. With fears of an impending recession playing on the minds of investors, it could be wise to buy fundamentally strong pharmaceutical stock AbbVie (ABBV). On the other hand, given its mixed fundamentals and profitability, it could…

Amidst the turmoil in the banking sector, high inflation, and the Fed’s restrictive monetary policy, the economy faces a threat of recession this year. However, fundamentally strong stocks AbbVie (ABBV) and Salesforce (CRM) might be worth adding to your watchlist. Read more.

Over the past year, the central bank has raised interest rates eight times to control inflation, which is still well above its 2% goal. The recent collapse of the financial system further complicates the Fed’s efforts in its fight against stubborn inflation. Amid this, it could be wise to invest…

Despite a drop in inflation, recent developments have been concerning. Moreover, the Fed is in a dilemma of stabilizing the banking industry or fighting inflation. With uncertainty looming over the stock market, high-quality blue-chip stocks Johnson & Johnson (JNJ), Coca-Cola (KO), and AbbVie (ABBV) could be solid additions to your…

Powell's testimony to keep the interest rates higher if required has created chaos in the markets, with the U.S. jobs report looming large for the future of monetary policy. Given the volatile market backdrop, fundamentally sound dividend-paying stocks AbbVie (ABBV), Cisco Systems (CSCO), Westlake Chemical Partners (WLKP), and Spok Holdings…

The stock market is anticipated to remain volatile due to stubbornly high inflation and the Fed’s rate hikes. Large-cap stocks tend to be safer investments amid market uncertainties. So, fundamentally sound large-cap stocks, AbbVie (ABBV), The Coca-Cola Company (KO), and Oracle (ORCL), which look poised for a bull run, might…

Amid the diminishing likelihood of a Fed pivot and recession odds soaring, a bear market could be expected anytime soon. Therefore, investors can scoop up quality stocks Walmart (WMT), AbbVie (ABBV), and CVS Health (CVS) now. Read on….

The pharma industry witnessed solid growth amid the pandemic. Moreover, with surging demand, rising investments in research and development, and increasing e-pharmacy channels, the industry is well-positioned for significant growth over the coming years. Therefore, investors could consider buying fundamentally sound pharma stocks Johnson & Johnson (JNJ), AbbVie (ABBV), and…

Despite recent signs of moderation in inflation, the better-than-expected January jobs data could force the Fed to raise interest rates even further. This is expected to keep the stock market highly volatile in the near term. Given a volatile market backdrop, investing in high-quality stocks AbbVie (ABBV), Cintas (CTAS), and…

The Fed will likely keep raising interest rates to bring inflation down to its desired level. This is expected to keep the stock market and the economy under pressure this year. Amid the uncertainty, investors looking for passive income could add fundamentally strong dividend-paying stocks AbbVie (ABBV), Valero Energy (VLO),…

While the better-than-expected GDP growth in the last quarter and declining inflationary pressures are raising optimism, macro uncertainties remain. With interest rate hikes expected to continue, recession possibilities cannot be ruled out. Therefore, fundamentally sound dividend-paying stocks, AbbVie (ABBV), Gilead Sciences (GILD), and Sisecam Resources (SIRE), could be worth investing…